A Phase I/II Study of Azacitidine in Combination With Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia
Phase of Trial: Phase I/II
Latest Information Update: 20 Jun 2018
At a glance
- Drugs Azacitidine (Primary) ; Azacitidine (Primary) ; Lenalidomide (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 21 Dec 2012 Lenalidomide dosage info conflicting in NCT and 9144642.
- 10 Dec 2012 Results were presented at the American Society of Hematology annual meeting, according to a Celgene International Sarl media release.
- 09 Aug 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.